Neurovalens
Entry
2025
Hold
1yr
Status
Active
Who owns Neurovalens?
Neurovalens is currently owned by Whiterock through Whiterock Growth Capital Fund (2024 vintage), since 2025. Across its history, Neurovalens has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
WhiterockWhiterock Growth Capital Fund · 2024 · Growth
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2017 · present
ACF InvestorsActive
2017 · present(9yr) · Angel CoFund · 2011 · VC
Clarendon Fund ManagersActive
2020 · present(6yr) · Co-Fund NI · 2012 · VC
WhiterockActive
2025 · present(1yr) · Whiterock Growth Capital Fund · 2024 · Growth
More from Whiterock Growth Capital Fund
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Neurovalens
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Neurovalens.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue